Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease

Kidney International

Volumn 56, Issue 1, 1999, Pages 253-260

  Berns, Jeffrey S ^a   Rudnick, Michael R ^b   Cohen, Raphael M ^b   Bower, John D ^b   Wood, Barry C ^b  

^a GRADUATE HOSPITAL   (United States)

^b NONE

Author keywords

Anemia; Cardiovascular disease; Hypertension; Interdialytic ambulatory blood pressure; RHuEPo

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; AMBULATORY MONITORING; ANEMIA; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART DISEASE; HEMATOCRIT; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0033002174     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00531.x     Document Type: Article

References (10)

1. ESCHBACH JW, ABDULHADI MH, BROWNE JK, DELANO BG, DOWNING MR, EGRIE JC, EVANS RW, FRIEDMAN EA, GRABER SE, HALEY NR, KORBET S, KRANTZ SB, LUNDIN AP, NISSENSON AR, OGDEN DA, PAGANINI EP, RADER B, RUTSKY EA, STIVELMAN J, STONE WJ, TESCHAN P, VAN STONE JC, VAN WYCK DB, ZUCKERMAN K, ADAMSON JW: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Ann Intern Med 111:992-1000, 1989
2. CANADIAN ERYTHROPOIETIN STUDY GROUP: Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Am J Nephrol 11:23-26, 1991
3. ABRAHAM PA, OPSAHL JA, PRAKASH R, KESHAVIAH PR, COLLINS AJ, WHALEN JJ, ASINGER RW, MCLAIN LA, HANSON G, DAVIS MG, HALSTENSON CE: Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. Am J Kidney Dis 16:438-446, 1990
4. VAN DE BORNE P, TIELEMANS C, VANHERWEGHEM J-L, DEGAUTE J-P: Effect of recombinant human erythropoietin therapy on ambulatory blood pressure and heart rate in chronic haemodialysis patients. Nephrol Dial Transplant 7:45-49, 1992
5. JONES MA, KINGSWOOD JC, DALLYN PE, ANDREW M, CHEETHAM A, BURWOOD R, SHARPSTONE P: Changes in diurnal blood pressure variation and red cell and plasma volumes in patients with renal failure who develop erythropoietin-induced hypertension. Clin Nephrol 44:193-200, 1995
6. LEBEL M, KINGMA I, GROSE JH, LANGLOI S: Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Am J Hypertens 8:545-551, 1995
7. IMAI Y, SEKINO H, FUJIKURA Y, MUNAKATA M, MINAMI N, HASHIMOTO J, SAKUMA H, WATANABE N, MISAWA S, NISHIYAMA A, ABE K: Pressor effect of recombinant human erythropoietin: Results of ambulatory blood pressure monitoring and home blood pressure measurements. Clin Exp Hypertens 17:485-506, 1995
8. LEBEL M, KINGMA I, GROSE JH, LANGLOIS S: Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients. J Am Soc Nephrol 9:97-104, 1998
9. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 30(Suppl 3):S192-S240, 1997
10. BESARAB A, BOLTON WK, BROWNE JK, EGRIE JC, NISSENSON AR, OKAMOTO DM, SCHWAB SJ, GOODKIN DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584-590, 1998